Canadian Government Overhauls Vaccine Injury Program
On Apr. 1, 2026, the Government of Canada assumed direct control of Canada’s vaccine injury compensation system, introducing changes aimed at improving how claims are processed and how support is delivered to vaccine injured individuals.1 The move followed an audit ordered by Health Minister Marjorie Michel in response to concerns about how the previous program […]
U.S. Fertility Rates Near Historic Lows
Fertility rates in the United States are now among the lowest levels ever recorded, based on provisional data released by the U.S. Centers for Disease Control and Prevention (CDC) earlier this month. According to the CDC report, the general fertility rate declined to 53.1 births per 1,000 women ages 15-44, down 23 percent since 2007, […]
The Right to Health Sovereignty
International cooperation on health is a widely accepted global good. Capacity building and development assistance reduce historic health inequalities and, as a result, strengthen economies. Management of cross-border infectious disease threats is best done through joint surveillance, data sharing, and response. Collaboration on norms and standards provides efficiencies and facilitates trade in health products. However, […]
Patients Request Blood from Donors Who Have Not Received mRNA COVID-19 Shots
A growing number of patients are requesting blood transfusions from donors who have not gotten the COVID19 shot, according to a Mar. 28, 2026 report published in the journal Transfusion. In the report, researchers at Vanderbilt Medical Center Medical Center evaluated 15 cases over a period of two years between 2024 and 2025 in which […]
Pfizer/Valneva Aim for FDA Approval of mRNA Shot for Lyme Disease
On Mar. 23, 2026, Pfizer, Inc. of New York City, NY and Valneva SE of Saint-Herblain, France announced that they would seek regulatory approval from the U.S. Food and Drug Administration (FDA) for an experimental mRNA (messenger ribonucleic acid) biologic shot against Lyme disease that they have jointly been developing since 2020. The shot, designated […]
Pfizer, BioNTech End mRNA COVID-19 Biologic Trial Early
After failing to recruit enough eligible volunteers to generate enough data in the U.S. to meet U.S. Food and Drug Administration (FDA) post-marketing evidence requirements, Pfizer, Inc. and BioNTech SE have halted a large clinical trial of their updated mRNA COVID-19 biologic. The study targeted healthy adults 50 to 64 years of age but fell […]